ATE437235T1 - Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix - Google Patents

Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix

Info

Publication number
ATE437235T1
ATE437235T1 AT03724033T AT03724033T ATE437235T1 AT E437235 T1 ATE437235 T1 AT E437235T1 AT 03724033 T AT03724033 T AT 03724033T AT 03724033 T AT03724033 T AT 03724033T AT E437235 T1 ATE437235 T1 AT E437235T1
Authority
AT
Austria
Prior art keywords
cell carcinoma
renal cell
prognosis
carboanhydrase
treatment selection
Prior art date
Application number
AT03724033T
Other languages
English (en)
Inventor
Matthew Bui
David Seligson
Arie Belldegrun
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE437235T1 publication Critical patent/ATE437235T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Gastroenterology & Hepatology (AREA)
AT03724033T 2002-04-16 2003-04-15 Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix ATE437235T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37319302P 2002-04-16 2002-04-16
US38446002P 2002-05-31 2002-05-31
PCT/US2003/011561 WO2003089659A1 (en) 2002-04-16 2003-04-15 Methods or renal cell carcinoma prognosis and treatment selection with carbonic anhydrase ix

Publications (1)

Publication Number Publication Date
ATE437235T1 true ATE437235T1 (de) 2009-08-15

Family

ID=29254515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724033T ATE437235T1 (de) 2002-04-16 2003-04-15 Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix

Country Status (6)

Country Link
US (1) US8936914B2 (de)
EP (1) EP1501939B1 (de)
AT (1) ATE437235T1 (de)
AU (1) AU2003230925A1 (de)
DE (1) DE60328477D1 (de)
WO (1) WO2003089659A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524634B2 (en) 2003-10-16 2009-04-28 Institute Of Virology, Slovak Academy Of Sciences MN/CA IX and cancer prognosis
AU2005241093B2 (en) * 2004-05-04 2008-06-05 Institute Of Virology Of Slovak Academy Of Sciences MN/CA IX/ CA9 and renal cancer prognosis
FR2928657B1 (fr) * 2008-03-14 2013-12-20 Chu Saint Etienne Chu Hopital Nord Methode, procede, et kit de diagnostic, pronostic, suivi d'un cancer
WO2010042765A1 (en) * 2008-10-08 2010-04-15 The Regents Of The University Of California Ca9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma
RU2431149C2 (ru) * 2009-01-19 2011-10-10 Государственное образовательное учреждение высшего профессионального образования "Белгородский государственный университет" Способ оценки почечной выживаемости у больных хроническим гломерулонефритом на основе данных о полиморфизме генов интерлейкинов
BR112015020061A8 (pt) 2013-02-22 2018-01-23 Wilex Ag composto alvo anidrase carbônica ix (caix) para tratamento de câncer, seus usos, composição farmcêutica, e método para diagnosticar, prognosticar e/ou classificar um câncer
CN105316343B (zh) * 2015-10-19 2018-09-28 李翀 Kcp基因突变序列、检测方法、以及kcp基因突变在区分肾癌干细胞中的应用
JP7806041B2 (ja) * 2020-10-13 2026-01-26 バイオセンス・ウエブスター・（イスラエル）・リミテッド 個人に応じた不整脈治療計画

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) * 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3766162A (en) * 1971-08-24 1973-10-16 Hoffmann La Roche Barbituric acid antigens and antibodies specific therefor
US4233402A (en) * 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
US6297041B1 (en) * 1992-03-11 2001-10-02 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6069242A (en) * 1992-03-11 2000-05-30 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6297051B1 (en) * 1997-01-24 2001-10-02 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US5981711A (en) * 1992-03-11 1999-11-09 Institute Of Virology, Slovak Academy Of Sciences MN-specific antibodies and hybridomas
US5989838A (en) * 1992-03-11 1999-11-23 Institute Of Virology, Slovak Academy Of Sciences Immunological methods of detecting MN proteins and MN polypeptides
US5387676A (en) * 1992-03-11 1995-02-07 Ciba Corning Diagnostics Corp. MN gene and protein
US6093548A (en) * 1992-03-11 2000-07-25 Institute Of Virology, Slovak Academy Of Sciences Detection and quantitation of MN-specific antibodies.
US5972353A (en) * 1992-03-11 1999-10-26 Institute Of Virology, Slovak Academy Of Sciences MN proteins, polypeptides, fusion proteins and fusion polypeptides
US6774117B1 (en) * 1992-03-11 2004-08-10 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6204370B1 (en) * 1992-03-11 2001-03-20 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6027887A (en) * 1992-03-11 2000-02-22 Institute Of Virology, Solvak Academy Of Sciences MN gene and protein
US5955075A (en) * 1992-03-11 1999-09-21 Institute Of Virology, Slovak Academy Of Sciences Method of inhibiting tumor growth using antibodies to MN protein
WO1995034650A2 (en) * 1994-06-15 1995-12-21 Ciba Corning Diagnostics Corp. Mn gene and protein
US7572891B2 (en) * 2000-02-14 2009-08-11 The Regents Of The University Of California Kidney-specific tumor vaccine directed against kidney tumor antigen G-250
AU2003217606C1 (en) * 2002-02-21 2008-07-17 Institute Of Virology Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IXs Coexpression with HER-2/neu/c-erbB-2 and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes

Also Published As

Publication number Publication date
US20050158809A1 (en) 2005-07-21
EP1501939A1 (de) 2005-02-02
EP1501939B1 (de) 2009-07-22
WO2003089659A1 (en) 2003-10-30
DE60328477D1 (de) 2009-09-03
US8936914B2 (en) 2015-01-20
AU2003230925A1 (en) 2003-11-03
EP1501939A4 (de) 2006-07-05

Similar Documents

Publication Publication Date Title
ATE551658T1 (de) Systeme, verfahren, schnittstellen und software zur automatisierten sammlung und integration von entitätsdaten in online-datenbanken und professionellen verzeichnissen
DE602004012485D1 (de) Vorrichtung, Verfahren und Rechnerprogramm zur Verwaltung von digitalen Zertifikaten
DE60304755D1 (de) Vorrichtung zur Bestimmung von Thrombosen tiefliegender Venen
DE60326012D1 (de) Verfahren zur Konzentration von Proteinen
DE602005012856D1 (de) Verfahren, Computerprogramm und System zur regulieren von E-mail
DE60319482D1 (de) Verfahren, Gerät und Computerprogramm zur Erzeugung von Alben
DE60313368D1 (de) Verfahren und Server zum Aktualisieren von Software
DE602004001904D1 (de) Verfahren und System zur Zuweisung von Ressourcen eines Computers
DE60313947D1 (de) System und verfahren zur kartierung von unregelmässigkeiten von hartem gewebe
DE60315829D1 (de) Automatisches verfahren und vorrichtung zur bestimmung des zustandes von bohrlochoperationen
ATE454474T1 (de) Verfahren und kit zur prognose von brustkrebs
GB0325653D0 (en) CST emulsions
EP1773317A4 (de) Verfahren zur behandlung von glycogen-oder polysaccharid-speicherkrankheit
DE60309299D1 (de) System und Verfahren zur Ablaufverfolgung von Banknoten
ATE533827T1 (de) Verfahren zur behandlung von unterirdischen formationen oder hohlräumen mit mikrogelen
ATE520781T1 (de) Verfahren zur veränderung des gehalts von speicherstoffen in pflanzen
DE112004001110D2 (de) System und Verfahren zur Bearbeitung von Werteinheiten
DE602005023517D1 (de) Verfahren zur bestimmung von genotoxizität
DE60328477D1 (de) Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix
DE60332422D1 (de) Unterstützungssystem zum Editieren von Inhalt, Computerprogramm und Inhaltsverarbeitungsverfahren
DE50309262D1 (de) Verfahren zur auswahl und/oder fertigung von automatisierungshardware
ATE505811T1 (de) Verfahren zur nassbehandlung von scheibenförmigen gegenständen
EP1786465A4 (de) Verfahren zur detektion und behandlung von autoimmunstörungen
DE60131545D1 (de) Verfahren zur behandlung von reaktiver arthritis oder schleimbeutelentzündung
DE602005003473D1 (de) Datenverarbeitungssystem und Verfahren zur Zuordnung von Zeitlagen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties